Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Endometriosis × Clear all

Phase

Status

Completed 17 Recruiting 7 Unknown 3 Terminated 2 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Conditions

Breast Neoplasms 604 Carcinoma, Non-Small-Cell Lung 406 Prostatic Neoplasms 350 Neoplasms 318 Multiple Myeloma 230 Colorectal Neoplasms 225 Lung Neoplasms 204 Neoplasm Metastasis 197 Melanoma 191 Ovarian Neoplasms 168 Pancreatic Neoplasms 167 Leukemia, Myeloid, Acute 166 Squamous Cell Carcinoma of Head and Neck 141 Recurrence 132 Glioblastoma 129 Lymphoma 125 Lymphoma, Non-Hodgkin 122 Carcinoma, Renal Cell 121 Stomach Neoplasms 111 Brain Neoplasms 110 Triple Negative Breast Neoplasms 109 Leukemia, Lymphocytic, Chronic, B-Cell 106 Head and Neck Neoplasms 105 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Lymphoma, Large B-Cell, Diffuse 100 Carcinoma, Hepatocellular 98 Urinary Bladder Neoplasms 92 Uterine Cervical Neoplasms 88 Sarcoma 88 Colonic Neoplasms 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04756037 2026-01-08

SERENE

Sumitomo Pharma Switzerland GmbH

Phase 3 Active not recruiting

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡